Evaluation of the hematological and immunological markers after the first and second doses of BNT162b2 mRNA vaccine.
Rafeeq M, Jabir MS, Al-Kuraishy HM, Jeddoa ZMA, Jawad SF, Najm MAA, Almulla AF, Elekhnawy E, Tayyeb JZ, Turkistani A, Alsfouk BA, Batiha GE.
Rafeeq M, et al. Among authors: turkistani a.
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2605-2614. doi: 10.26355/eurrev_202403_35766.
Eur Rev Med Pharmacol Sci. 2024.
PMID: 38567619
Free article.